Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.
Jacob
Abraham
A
Department of Haematology and Renal Medicine, Royal Wolverhampton Hospitals, New Cross Hospital, Wolverhampton, West Midlands, WV10 0QP. ABRAHAM.JACOB@RWH-TR.NHS.UK
Sandhu
Kanwaljit
K
Nicholas
Johann
J
Jones
Helen
H
Odum
Jonathan
J
Rylance
Paul
P
Carmichael
Paul
P
Jackson
Maurice
M
Handa
Sunil
S
Macwhannell
Alan
A
Basu
Supratik
S
Wahid
Faisal
F
Casadevall
Nicole
N
Mufti
Ghulam
G
Macdougall
Iain
I
D000906:Antibodies / Q000276:immunology*; D000068256:Darbepoetin alfa; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D006397:Hematinics / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000276:immunology; D006435:Renal Dialysis; D013997:Time Factors
D000906:Antibodies; D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa